A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1070 participants.
Also called NCT07527299
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,070 participants
- Sponsor
- Registry
-
NCT07527299
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07527299. Randomized; single masking; primary purpose treatment. Start 2026-08-26 (actual); primary completion 2028-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Acronym
- SPAA PFA
- Condition
- Atrial Fibrillation
- Intervention (Device)
- VARIPULSE Catheter System
- Intervention (Device)
- LAAO Device
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct07527299- Content hash
8a4572cfae5be74bc1346ff5c256f228d1de846f813ca30e404c3ee51a32a288